Search results for: Value-Based Pricing
Filter search results
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy
1 March 2019
…capture all that is important to patients and caregivers. Based on the discussion, we highlight four possible strategies for improving the quantity and quality of data available to inform decisionmakers…
Spotlight on OHE: Opportunity Costs of NICE Decisions in Wales and HESG 2015
20 January 2015
…in healthcare spending)” written by Beth Woods, Paul Revill, Mark Sculpher and Karl Claxton of the University of York. By emphasising that thresholds should be based on forgone benefit rather…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
…variation in access, supporting the Pharmaceutical Price Regulation Scheme (PPRS), analysing the value of medicines in routine practice, and monitoring the implementation of guidance from bodies such as the National…
Newly Published Analysis: Dementia: the R&D Landscape
16 November 2015
…successes and failures of dementia treatments, based on a selective literature review A pipeline analysis of dementia treatments A comparison between dementia and other therapy areas. Parts 2 & 3…
2018 OHE Annual Report to the Charity Commission
1 November 2019
…the subject of health economics and health care policy; and using health economics methods to produce evidence-based health policy and health care management that contributes to a more efficient and…
Dementia: The R&D Landscape
1 November 2015
…published elsewhere*. The report begins with a brief overview of the current thinking on the reasons for successes and failures of dementia treatments, based on a selective literature review. Key…
OHE Lunchtime Seminar: The UK Biotech Sector and Brexit: Past Performance and Future Prospects
25 September 2017
…science-based industry. While the US sector has enjoyed a virtuous cycle of commercial success and re-investment, the UK sector has suffered from a pronounced boom and bust in the financing…
An Insurance Framework for Funding New Antibiotics
22 September 2017
…of new antibiotics in the long-term. A new paper entitled “Time for a Change in How New Antibiotics are Reimbursed: Development of an Insurance Framework for Funding New Antibiotics based…
Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market
12 December 2017
…which provides headline results according to various ‘scenarios’; A detailed Technical Annex which provides methods and results for each of the individual analyses upon which the headline results are based….